RST Introduces 'Demron-C' Line of Covid-19 Anti-Viral, Reusable

RST introduces Demron-C line of Covid-19 anti-viral reusable personal protective equipment (PPE) for Coronavirus first responders & healthcare workers

Canadian researchers lead development and testing of promising treatment for COVID-19 variants

Frontiers Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions - ScienceDirect

Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection - ScienceDirect

Current trends and challenges in point-of-care urinalysis of biomarkers in trace amounts - ScienceDirect

Sensors, Free Full-Text

Service/Supplier articles and careers information on BioSpace

RST Introduces 'Demron-C' Line of Covid-19 Anti-Viral, Reusable Personal Protective Equipment (PPE) for Coronavirus First Responders and Healthcare Workers

RST Introduces 'Demron-C' Line of Covid-19 Anti-Viral, Reusable Personal Protective Equipment (PPE) for Coronavirus First Responders and Healthcare Workers

Respiratory Virus Report, Week 49 - ending December 9, 2023

Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection - ScienceDirect

Advantages of imprinted polymer electrodes for electrochemical pathogen detection - ScienceDirect

Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection - ScienceDirect

What We Read: Pandemic Edition